Hester Biosciences Limited is all set to expand into the rapidly growing Pet Care sector this April. India has the fastest-growing pet care market worldwide, with it growing by 14% in 2022, making this an exciting and valuable opportunity for the poultry vaccine giant.
Hester's comprehensive knowledge of animal biology, cutting-edge R&D capabilities, and four-decade-long experience in animal healthcare gives them an advantage. This expansion perfectly aligns with their core beliefs and vision to provide better health for human beings through healthy animals.
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and specialty products. The goal is to create and innovate products tailored to pets and their needs. Hester plans to eventually expand by way of pet biologicals and diagnostics. The complete portfolio will target both veterinarians and pet parents with offerings that cater to the evolving needs of pets.
The pet care sector may have started off decades ago as a neglected afterthought but has quickly evolved into an empathetic and emotive sector. The Indian population is realising how care and compassion to pets can create a positive change in their own lives and mental health. With this thought at the forefront, Hester's pet care project is tentatively scheduled to hit the floor in April 2022.
Shares of Hester Biosciences Limited was last trading in BSE at Rs. 2469.90 as compared to the previous close of Rs. 2380.55. The total number of shares traded during the day was 218 in over 70 trades.
The stock hit an intraday high of Rs. 2495.00 and intraday low of 2379.85. The net turnover during the day was Rs. 529392.00.